Your English writing platform
Discover LudwigExact(2)
"Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial". Journal of the American College of Cardiology 32, no.
The higher risk of relapse of disease observed with TPF-C in comparison to TPF in the Paradigm trial may reflect the greater proportion of patients with T3/4 and N2c/3 classification in our study.
Similar(58)
In the TAX 324 and Paradigm trials, relapse of disease occurred in 56% and 24% of patients given TPF followed by CRT, respectively 3, 10, 11.
Therefore on half of the trials in the experimental paradigm the trial onset was shifted by a fixed amount of time.
Consider a discrete variable x that can take values from 1 to K. In our paradigm each trial comprises two stimuli, CS and IS, that induce four events: thumb validly cued, thumb invalidly cued, little finger validly cued, and little finger invalidly cued (i.e., K = 4).
In the present paradigm, valid trials indeed represent 50% of the non-neutral trials, as compared to 100% in the ANT studies.
Clinical trials are critical for medical decision-making, however, under the current paradigm, clinical trials are fraught with problems including low enrollment and high cost.
While this has become the traditional paradigm, recent trials have suggested the need for additional approaches.
The anterior N2 and P3 waves of event related potentials (ERPs) in the GO/NOGO paradigm in trials related to preparatory set violations in previous studies were inconsistently associated either with action inhibition or conflict monitoring operations.
"We think this is a groundbreaking, perhaps paradigm-shifting trial," said Steven Austad, chairman of biology at the University of Alabama, Birmingham, and scientific director of the American Federation for Aging Research AFARR).
As I reported previously (here and here), early on Monday Novartis disclosed that the PARADIGM-HF trial testing LCZ696, a novel, first-in-class Angiotensin Receptor Neprilysin Inhibitor (ARNI), had been stopped early.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com